Loading...
Printed on 7/20/2026
For informational purposes only. This is not medical advice.
The Pasero Opioid-Induced Sedation Scale (POSS) is a nursing safety framework used to monitor sedation depth during opioid therapy. It helps identify oversedation risk and supports practical action plans, including dose review and escalation when severe sedation is present.
Formula: Ordinal bedside scale: S, 1, 2, 3, 4. Higher numeric level indicates greater opioid-related sedation severity.
Save your results with a free account
Keep a history of calculations, favorite tools, and access your dashboard anytime.
Observe the patient's level of arousal and response to stimulation. Assign the appropriate POSS level: S = sleep but easily aroused (normal sleep); 1 = awake and alert; 2 = slightly drowsy, easily aroused; 3 = frequently drowsy, arousable, drifts off during conversation — this is the UNACCEPTABLE threshold; 4 = somnolent with minimal or no response to verbal or physical stimulation — this is an emergency.
Assess POSS at defined intervals: every 1–2 hours for the first 24 hours post-operatively in opioid-naive patients; every 2–4 hours on general surgical floors once stable. Always assess POSS before giving additional opioid doses. High-risk patients (obese, sleep apnea, elderly, concurrent sedatives) require more frequent monitoring regardless of current POSS level.
POSS S and 1–2: acceptable — continue monitoring. POSS 3: UNACCEPTABLE — reduce opioid dose 25–50%, increase monitoring frequency, avoid additional opioids until level improves, notify physician. POSS 4: EMERGENCY — stop all opioids, attempt to rouse patient with sternal rub or painful stimulation, call for help immediately, apply supplemental oxygen, consider naloxone 0.1–0.4 mg IV if respiratory rate <8 or SpO2 <90%.
Surgical Nurses & PACU Staff
POSS was specifically designed for the post-operative setting where opioid-naive patients receive IV and oral opioids after surgery. The critical 24–48 hour post-operative window carries the highest risk of opioid-induced respiratory depression. POSS provides nurses with a clear action framework — POSS 3 triggers dose reduction before respiratory depression becomes critical.
Pain Management Nurses
Patients on IV PCA are at continuous risk of opioid accumulation from demand dosing and basal rates. POSS monitoring every 1–2 hours in the first 24 hours of PCA therapy detects early sedation before respiratory compromise. A POSS of 3 during PCA therapy should prompt PCA lock-out, basal rate reduction, and physician reassessment.
Acute Pain Service Teams
Acute pain services integrate POSS into standardized opioid monitoring protocols alongside respiratory rate and SpO2. POSS 3 as a nursing-led intervention point empowers nurses to reduce opioid doses without waiting for physician orders in facilities with pre-approved nursing protocols, reducing response time to oversedation events.
Hospitalists & Medical Nurses
Opioid-naive patients, elderly patients, patients with obstructive sleep apnea, and those receiving concurrent benzodiazepines or antihistamines are at highest risk for POSS 3–4 events. Proactive monitoring protocols with more frequent POSS assessments and multimodal analgesia strategies reduce the need for opioid doses in these high-risk groups.
Nurse Educators & Quality Improvement Teams
POSS-based protocols enable nurses to independently intervene on opioid safety without waiting for physician review. Standing orders tied to POSS 3 (dose reduction) and POSS 4 (naloxone administration) have been shown in quality improvement studies to reduce opioid-related adverse events on surgical floors.
Unlike generic sedation scales (Ramsay, RASS) designed for ICU sedation depth, POSS was specifically developed by Pasero and McCaffery for opioid-induced sedation monitoring in post-operative patients. This context-specificity is its strength — it provides a practical action framework for nurses managing post-op patients outside the ICU.
Never administer an additional opioid dose without first assessing the POSS. A patient reporting pain at POSS 2 may receive an additional dose after careful assessment. A patient at POSS 3 reporting pain should NOT receive more opioids — the sedation itself indicates accumulation risk. Address pain through non-opioid adjuncts until POSS improves.
POSS 4 (unresponsive) is a respiratory emergency where the window for simple dose reduction has passed. The clinical value of POSS is detecting POSS 3 early and intervening with dose reduction, stimulation, and increased monitoring BEFORE the patient deteriorates to POSS 4. POSS 3 is the key decision point in the algorithm.
POSS S represents normal sleep that is easy to arouse — when you call the patient's name, they open their eyes and respond appropriately. POSS 3 is arousal difficulty during an awake interaction — the patient drifts off mid-conversation and is difficult to keep aroused. If unsure, wake the patient fully; if they return to conversation normally, it is POSS S or 1.
Patients at highest risk for opioid-induced respiratory depression include: opioid-naive patients, elderly patients (>65 years), obese patients (BMI >35), patients with known or suspected obstructive sleep apnea, patients on concurrent CNS depressants (benzodiazepines, antihistamines, antipsychotics, alcohol), and patients with neuromuscular disease. These patients should be monitored every 1–2 hours regardless of current POSS level.
SpO2 may remain acceptable (above 90–94%) for several minutes after the onset of hypoventilation due to supplemental oxygen and physiological buffering. POSS detects early central nervous system depression from opioids before hypoxemia develops. Relying on SpO2 alone as the primary monitor gives false reassurance — use POSS to detect the CNS effects of opioids early.
For POSS 4 with hypoxemia (SpO2 <90%) or respiratory rate <8: dilute naloxone 0.4 mg/mL to 0.1 mg/mL (dilute 1 mL with 3 mL NS) and give 0.1 mg IV every 2–3 minutes. Use the lowest effective dose to reverse respiratory depression without precipitating acute opioid withdrawal (severe pain, agitation, hemodynamic instability). The half-life of naloxone (60–90 min) is shorter than most opioids — re-sedation can occur and may require naloxone infusion.
The most effective strategy to prevent high POSS scores is reducing opioid requirements through multimodal analgesia: scheduled acetaminophen (1 g q6–8h), NSAIDs or COX-2 inhibitors (unless contraindicated), regional anesthesia (nerve blocks, epidurals), ketamine (subanesthetic doses), and non-pharmacological measures (ice, positioning, distraction). Fewer opioids given = lower peak opioid levels = lower POSS risk.
End-tidal CO2 (EtCO2) monitoring via nasal cannula sensor provides real-time respiratory rate and waveform data that can detect hypoventilation and apnea before SpO2 falls. For high-risk opioid patients (POSS ≥3 history, known OSA, heavy opioid doses), continuous capnography in addition to POSS monitoring provides the earliest warning of respiratory compromise.
POSS developed by Pasero & McCaffery (Am J Nurs 2002) for post-operative opioid monitoring. POSS 3 as the intervention threshold validated by Pasero et al. (J Perianesth Nurs 2009). The Joint Commission and ISMP (Institute for Safe Medication Practices) recommend structured sedation monitoring for patients on opioids. A quality improvement study by Jungquist et al. (Pain Manag Nurs 2012) demonstrated POSS-guided nursing interventions reduced opioid-related adverse events.
Lower POSS levels indicate acceptable or mild sedation, while levels 3 to 4 indicate escalating opioid safety concern and potential respiratory depression risk.
Use POSS after opioid administration and during ongoing opioid therapy in inpatient and procedural settings, especially with dose changes or concurrent sedatives.
POSS is an observational scale and does not replace full respiratory assessment, pulse oximetry/capnography trends, or cause-specific evaluation of altered mental status.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.
Calculate morphine milligram equivalents (MME) for opioid medications using CDC conversion factors. ≥50 MME/day warrants caution; ≥90 MME/day carries significantly increased overdose risk.
OpenMental HealthScreen risk of opioid misuse with the Opioid Risk Tool before initiating long-term opioid therapy.
OpenPharmacyCalculate IV infusion rates in mL/hr and drops per minute from volume, time, and drop factor. Essential nursing and pharmacy calculator for safe, accurate IV fluid and medication administration.
Open